Tokyo, Japan

Koichiro Yoneyama

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Koichiro Yoneyama: Innovator in Coagulation Factor Research

Introduction

Koichiro Yoneyama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of blood coagulation.

Latest Patents

Yoneyama holds a patent for "Methods of using a bispecific antibody that recognizes coagulation factor IX and/or activated coagulation factor IX and coagulation factor X and/or activated coagulation factor X." The objective of this invention is to provide an effective pharmaceutical composition or dosage regimen for preventing and/or treating bleeding, as well as diseases associated with bleeding. His research indicates that administering a pharmaceutical composition comprising a bispecific antigen-binding molecule can effectively prevent and treat bleeding-related conditions.

Career Highlights

Throughout his career, Yoneyama has worked with prominent companies in the pharmaceutical industry, including Chugai Pharmaceutical Co., Ltd. and F. Hoffmann-La Roche AG. His work has been instrumental in advancing medical treatments related to coagulation factors.

Collaborations

Yoneyama has collaborated with notable professionals in his field, including Christophe Schmitt and Kenji Shinomiya. These collaborations have contributed to the development of innovative solutions in the pharmaceutical sector.

Conclusion

Koichiro Yoneyama's work in the field of coagulation factors has led to significant advancements in medical treatments. His innovative approach and collaborations with industry leaders highlight his impact on pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…